Geode Capital Management’s RESPONSE GENETICS, INC COMMON SHS (DELAWARE) RGDX Stock Holding History

Geode Capital Management’s Portfolio RGDX Stock Details RGDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-99,700	Closed	-$32K	–	4198
2015 Q2	$32K	Hold	99,700	–	–	﹤0.01%	3908
2015 Q1	$45K	Hold	99,700	–	–	﹤0.01%	3863
2014 Q4	$31K	Hold	99,700	–	–	﹤0.01%	3927
2014 Q3	$68K	Hold	99,700	–	–	﹤0.01%	3809
2014 Q2	$91K	Buy	99,700 +84,697	+565%	+$88.6K	﹤0.01%	3717
2014 Q1	$17K	Buy	+15,003	New	+$20.9K	﹤0.01%	3805

Geode Capital Management's RGDX Position: Q3 2015 in Review

Geode Capital Management sold out of RESPONSE GENETICS, INC COMMON SHS (DELAWARE) (RGDX) in Q3 2015, closing a stake of 99,700 shares — an estimated $32K sold.

Geode Capital Management first reported a position in RGDX in Q1 2014 and held it in 6 quarters. The position peaked at $91K in Q2 2014. 1 fund tracked by Wall St. Rank holds RGDX as of Q3 2015.

Geode Capital Management reported no remaining RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position as of Q3 2015 after selling out during the quarter.
Geode Capital Management sold 99,700 RESPONSE GENETICS, INC COMMON SHS (DELAWARE) shares in Q3 2015, an estimated $32K.
Geode Capital Management first reported a position in RESPONSE GENETICS, INC COMMON SHS (DELAWARE) in Q1 2014 and held it in 6 quarters.
Geode Capital Management's RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position peaked at $91K in Q2 2014.
1 fund tracked by Wall St. Rank held RESPONSE GENETICS, INC COMMON SHS (DELAWARE) as of Q3 2015.

Based on Geode Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.